Has COVID-19 Reshaped the Microfluidics Industry?Thursday, 10 September 2020 at 09:00 Add to Calendar ▼2020-09-10 09:00:002020-09-10 10:00:00Europe/LondonHas COVID-19 Reshaped the Microfluidics Industry?Lab-on-a-Chip and Microfluidics Europe 2020 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com The past few months have seen a new biological threat, the COVID-19 infection, caused by the SARS-CoV-2 virus, reshape the entire diagnostics ecosystem. Indeed, the need for respiratory pathogen testing has risen sharply while entire countries lockdown has resulted in a decline in other medical procedures and diagnostics. There have obviously been some winners and some losers in the field. What has the effect of the pandemic been on the microfluidics industry in particular? In this talk, Sébastien Clerc will explain Yole’s vision of how the virus has opened up new opportunities for diagnostics companies, and explain what the impact is for microfluidic companies at different levels of the supply chain and what it could be on the short and long-term future. |